Search results for: 'structural determination techniques analysis'

Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies.  Risks due...

This research service presents an overview of hospital-acquired infections, global scenario, key incidences and trends in Malaysia. The study is segmented based on the type of infections  blood stream, respiratory tract, urinary tract, surgical site and clinical sepsis. It provides in-depth geographical analysis of HAI incidence and trends in thes...

This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...

This country specific healthcare IT market analysis looks at the healthcare delivery system structure, financing, resources, expenditure, IT bodies and initiatives, drivers and restraints, market forecasts, price, technology and procurement trends, potential target markets, barriers to entry and key factors for success for new market entrants.

The objective of this Strategic Analysis Service is to equip the C-level and senior exceutives of global healthcare and life sciences companies with cutting edge research, strategic planning, and structured advisory services. The Strategic Analysis of World Pediatric Pharmaceuticals Market provides insight into the present challenges and growth opp...

Research was carried out in the medical device industries of Ghana and Nigeria. Medical imaging markets were specifically covered in this study. Market sizes were determined for 2007, as well as forecasts for the period 2008-2014, for each the medical imaging segments, and for each country. In addition, market dynamics, such as challenges, drivers ...

This research service considers products and companies in the therapeutic beds market in the United States. The market has seen many technology advancements in the last decade. Therefore, a thorough understanding of revenue forecasts, unit forecasts, technological advances, and pricing analyses are provided for the markets various segments includi...

This strategic analysis service provides detailed analysis of world oligonucleotides markets and includes both RNA and DNA oligos markets. The service in powerpoint format (approximately 115 slides) focuses not just only on the oligonucleotides markets but also on strategies for differentiation amongst oligonucleotides suppliers/manufacturers.

This research service provides a detailed overview and analysis of ten specialty pharmaceutical companies. They have been chosen by taking into account certain critical indicators such as revenues, research and development (R&D) expenditure, current drug pipeline, earnings per share, stock price appreciation, return on investment, and net income.